CAFs promote peritoneal metastasis of ovarian cancer (S1); CSIOVDB analysis of CXCL14 expression in ovarian cancer (S2); CXCL14 inhibition attenuates ovarian cancer metastasis in vivo (S3); LINC00092 silencing induced increase of cleaved caspase-3 in specimens of ovarian cancer peritoneal metastasis model in nude mice (S4); Enhanced LINC00092 expression in ovarian cancer cells could offset the metastasis-attenuating effects of CXCL14 knockdown in CAFs (S5); RIP experiments were performed using an antibody against EZH2 on extracts from A2780s cell line (S6); Correlation between LINC00092 level and PFKFB2 expression in ovarian cancer (S7); PFKFB2 in the maintenance of metastatic phenotype of ovarian cancer (S8); Enhanced LINC00092 expression in ovarian cancer cells could offset the metastasis-attenuating effects of CXCL14 knockdown in CAFs (S9); The necessity and sufficiency of CAF-secreted CXCL14, LINC00092 in ovarian cancer cells and PFKFB2 in ovarian cancer cells in the process of metastasis formation in ovarian cancer (S10); A schematic model summarizing the proposed mechanistic model of the a positive feedback loop between CXCL14-positive CAFs and ovarian cancer cells favorable for cancer metastasis by manipulating Warburg effect (S11).